MedPath

Additional tubal flushing with Lipiodol Ultra fluid after the diagnosis of tubal patency at transvaginal hydrolaparoscopy: a pilot feasibility study in 50 patients

Not Applicable
Completed
Conditions
<p>50 subfertile women who showed tubal patency of at least one tube at THL.</p>
10033283
Registration Number
NL-OMON29484
Lead Sponsor
Board of Management Máxima MC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

- Age > 18 years - Subfertility, defined as lack of conception despite 12 months of unprotected intercourse - Tubal patency of at least one Fallopian tube

Exclusion Criteria

- Pregnancy - Chlamydia-infection, an acute pelvic inflammation - Immobile uterus not allowing THL - Women with an uterus in retroversion flexion, as a THL is not feasible in these women - Masses or cysts in the pouch of Douglas or ovarian cysts, interfering with THL - Iodine allergy - Allergy for methylene blue or oil containing contrast - Manifest thyroid dysfunction - Patients with traumatic injuries, recent major haemorrhage or bleeding (not including the menstruation) - The use of the following medicinal products: beta blockers, vasoactive substances, angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, interleukin II (IV route) - Male subfertility defined as a post-wash total motile sperm count < 3 million spermatozoa/mL - Not willing or able to sign the consent form.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary objective of this pilot study is to determine the feasibility of additional flushing of the fallopian tubes with Lipiodol Ultra Fluid, in terms of; the appearance of the oil at the tubal fimbriae, the appearance of mucus debris from the tubal fimbriae and the pain and acceptability scores of the patients.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary objectives are the number and nature of adverse events, the influence on the thyroid function of the mother and the off-spring, and the amount of oil contrast that is necessary per procedure. The ongoing pregnancy rate, live birth rate and the mode of conception (IVF vs non-IVF) will be compared to the results from a previous study (van Kessel et al.).</p><br>
© Copyright 2025. All Rights Reserved by MedPath